MFNG and sarcoma: High expression of MFNG was also indicative of poor prognosis in patients with LUAD, thymoma (THYM), uterine corpus endometrial carcinoma (UCEC), endocervical adenocarcinoma (CESC), (sarcoma) SARC, and THYM (Fig. 3B).